Paniti Sukumvanich is Gynecologic Oncologist; Assistant Professor, School of Medicine at UPMC. OpenAlex indexes 340 publications with 4,186 citations (h-index 34).
Data verified 11 Oct 2026
Overview
Updated 15 Oct 2026
Paniti Sukumvanich is Gynecologic Oncologist at UPMC (University of Pittsburgh Medical Center), UPMC Magee-Womens Hospital Gynecologic Oncology. The public record shows 340 publications with 4,186 citations (h-index 34), centered on Endometrial and Cervical Cancer Treatments, Ovarian cancer diagnosis and treatment, BRCA gene mutations in cancer. It also documents industry payments reported by 4 companies.
- Most recent indexed publication: 2024 · Clinical cancer research
- Top research focus: Endometrial and Cervical Cancer Treatments
- Open Payments reporting from 4 companies
Generated from the cited public record · current as of 15 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 1 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 74.
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Contact
No public contact details on file. This person's NPPES record doesn't include a practice address or telephone number. Why? →
Clinical trials
We didn't find any investigator roles for this person on ClinicalTrials.gov. Why? →
Industry payments
Updated 15 Oct 2026
4 companies reported payments to CMS in program years 2022–2025. These are public disclosures, not judgments. The latest:
- AstraZeneca Pharmaceuticals LPProgram year20251 payment
- Ethicon US, LLCProgram year20251 payment
- AstraZeneca Pharmaceuticals LPProgram year20242 payments
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Congress activity
Updated 15 Oct 2026
35 congress contributions (2005–2026) across AACR, ASCO, ASTRO, SABCS per OpenAlex. The most recent:
- Examining the Impact of Combined P53 Status and PD-L1 Expression on Vulvar Cancer Outcomes
ASTRO Annual Meeting
ASTRO2024Co-author - Ovary Sparing IMRT for Locally Advanced Cervical Cancer after Laparoscopic Ovarian Transposition
ASTRO Annual Meeting
ASTRO2024Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 15 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
Most-cited works
by citation count (OpenAlex)- 01
- 02
- 03USA Endometrial Cancer Projections to 2030: Should we be Concerned?Article235 citations2014
- 04
- 05
Network
Updated 15 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 15 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/paniti-sukumvanich-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 15 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →providers.upmc.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →providers.upmc.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →providers.upmc.com ↗
Secondary affiliations
appointments beyond the home institution- Fellowship
Montefiore Medical Center/Albert Einstein College of Medicine; Fellowship, Memorial Sloan-Kettering Cancer Center (2005); Residency, University of Pittsburgh Medical Center
2005verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →providers.upmc.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Baha Sibai, MD
McGovern Medical School at UTHealth Houston
Robert Coleman, MD
Vaniam Group
Kathleen Moore, MD
University of Nebraska Medical Center
Bradley Monk, MD
Florida Cancer Specialists & Research Institute